Apyx Medical Corporation (NASDAQ:APYX) has scheduled a conference call for 9th November 2020 at 8:00 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website apyxmedical.com
Earnings Expectation
Apyx Medical Corporation is reporting third quarter financial results on Monday 9th November 2020, before market open.
According to analysts surveyed by Thomson Reuters, APYX is expected to report 3Q20 loss of $ 0.16 per share from revenue of $ 5.68 million.
For the full year, analysts anticipate top line of $ 22.18 million, while looking forward to loss of $ 0.51 per share bottom line.
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.
